SEC Comment Letter 0000000000-26-005526 to GeoVax Labs, Inc. (GOVX)
GeoVax Labs, Inc.
Date: June 1, 2026 · CIK: 0000832489 · Accession: 0000000000-26-005526
AI Filing Summary & Sentiment
Reasoning
File numbers found in text: 333-296214
Letter
June 1, 2026 David Dodd President & Chief Executive Officer GeoVax Labs, Inc. 1955 Lake Park Drive, Suite 300 Smyrna, GA 30080 Re: GeoVax Labs, Inc. Registration Statement on Form S-1 Filed May 26, 2026 File No. 333-296214 Dear David Dodd: This is to advise you that we have not reviewed and will not review your registration statement. Please refer to Rules 460 and 461 regarding requests for acceleration. We remind you that the company and its management are responsible for the accuracy and adequacy of their disclosures, notwithstanding any review, comments, action or absence of action by the staff. Please contact Alan Campbell at 202-551-4224 with any questions. Sincerely, Division of Corporation Finance Office of Life Sciences cc: F. Reid Avett, Esq.
Show Raw Text
June 1, 2026 David Dodd President & Chief Executive Officer GeoVax Labs, Inc. 1955 Lake Park Drive, Suite 300 Smyrna, GA 30080 Re: GeoVax Labs, Inc. Registration Statement on Form S-1 Filed May 26, 2026 File No. 333-296214 Dear David Dodd: This is to advise you that we have not reviewed and will not review your registration statement. Please refer to Rules 460 and 461 regarding requests for acceleration. We remind you that the company and its management are responsible for the accuracy and adequacy of their disclosures, notwithstanding any review, comments, action or absence of action by the staff. Please contact Alan Campbell at 202-551-4224 with any questions. Sincerely, Division of Corporation Finance Office of Life Sciences cc: F. Reid Avett, Esq.